| Structure | Chemical Name | CAS | MF |
|
PROSTAGLANDIN D SYNTHASE (HEMATOPOIETIC) BLOCKING PEPTIDE
|
|
C65H93N19O24
|
|
prostatic adenocarcinoma cytosol protein
|
|
|
|
PROSTAGLANDIN E1-[5,6-3H(N)]
|
20045-36-7
|
C20H32O5T2
|
|
PROSTAGLANDIN B2
|
13367-85-6
|
C20H30O4
|
|
|
ProstateSpecificAntigen(Psa),Total
|
|
|
|
PROSTACYCLIN SODIUM SALT
|
61849-14-7
|
C20H33NaO5
|
|
Prosta-5,13-dien-1-oic acid, 9-(methoxyimino)-11,15-bis[(trimethylsily l)oxy]-, trimethylsilyl ester, (5Z,9Z,11alpha,13E,15S)-
|
39003-23-1
|
|
|
|
PROSTAGLANDIN D2-BIOTINIMIDE
|
|
C35H58N4O6S
|
|
|
prostate-derived STE20-like kinase
|
|
|
|
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, (11alpha,13E )-(+-)-
|
66792-31-2
|
C21H36O5
|
|
|
ProstateSpecificAntigen(Psa)Free
|
|
|
|
|
PROSTHESES
|
|
|
|
Prostantherol, derivative of
|
2125862-42-0
|
C14H22O
|
|
PROSTAGLANDIN B1
|
35900-16-4
|
C22H38O5
|
|
|
Prostamed
|
|
|
|
|
PROSTATE SPECIFIC ANTIGEN
|
|
|
|
|
prostaglandin EP2 receptor
|
|
|
|
|
prostaglandin synthase inhibitor, endogenous
|
|
|
|
|
prostate epithelium-specific ets transcription factor
|
|
|
|
|
Prostaglandin Endoperoxides
|
|
|
|
|
Prostat extract
|
|
|
|
PROSTACYCLIN
|
63859-31-4
|
C20H32O5
|
|
|
prostaglandin-generating factor of anaphylaxis
|
|
|
|
|
prostromelysin
|
|
|
|
PROSTAGLANDINS E2 METHYL ESTER
|
36210-00-1
|
C22H36O5
|
|
|
PROSTATESPECIFICANTIGEN(PSA),RABBITANTI-HUMAN
|
|
|
|
|
PROSTAGLANDIN J2 LIPID MAPS
|
|
|
|
prostaglandin I2 11-methyl ether
|
79743-30-9
|
C21H34O5
|
|
(+)-Prostaglandin E1
|
38360-96-2
|
C20H34O5
|
|
|
prostaglandin E1 monooxygenase
|
|
|
|
Prosta-8(12),13-dien-1-oic acid, 9-(methoxyimino)-15-[(trimethylsilyl) oxy]-, trimethylsilyl ester, (13E,15S)-
|
56009-43-9
|
C27H51NO4Si2
|
|
|
prostate-derived factor protein
|
|
|
|
|
Prostaglandins A, Synthetic
|
|
|
|
|
Prostaglandins B
|
|
|
|
|
prostatic estramustine-binding protein
|
|
|
|
|
PROSTATESPECIFICANTIGEN(PSA),TOTAL,RABBITANTI-HUMAN,EIAKIT
|
|
|
|
PROSTAGLANDIN E SYNTHASE-2 (MICROSOMAL) BLOCKING PEPTIDE
|
|
C80H126N24O24S
|
|
PROSTAGLANDIN J2
|
60203-57-8
|
C20H30O4
|
|
|
prostaglandin EP3 receptor
|
|
|
|
Prosta-5,13-dien-9,11,15-triol-1-oic acid, methyl ester, triacetate
|
|
C27H42O8
|
|
PROSTAGLANDIN H1
|
52589-22-7
|
C20H34O5
|
|
PROSTGLANDIN E1-ALPHA-CYCLODEXTRIN COMPLEX
|
|
C56H92O34
|
|
|
Prostaglandin-A2-(3,3,4,4,-D4)
|
|
|
|
prostaglandin F2 ethyl ester
|
53764-89-9
|
C22H38O5
|
|
PROSTAGLANDINS F2ALPHA METHYL ESTER
|
33854-16-9
|
C21H36O5
|
|
|
prostaglandin E1-hexyl-sepharose
|
|
|
|
|
prostacyclin receptor
|
|
|
|
|
Prostaglandin-Endoperoxide Synthase
|
39391-18-9
|
|
|
|
prostaglandin 600
|
66758-34-7
|
|
|
Dinoprost tromethamine
|
38562-01-5
|
C24H45NO8
|
|
|
prostaglandin H2 9-cyclic ether
|
|
|
|
|
PROSTATESPECIFICGENE-1,HUMAN,RECOMBINANT
|
|
|
|
|
PROSTAGLANDIN E2 ETHANOLAMIDE LIPID MAPS
|
|
|
|
|
PROSTAGLANDIN H2 LIPID MAPS
|
|
|
|
|
prostatic secretory glycoprotein p25
|
|
|
|
|
PROSTAGLANDIN-E2-BSA,RABBITANTI-
|
|
|
|
Prosta-5,13-dien-1-oic acid, 9-(methoxyimino)-11,15-bis[(trimethylsily l)oxy]-, trimethylsilyl ester, (8xi,12xi)-
|
72377-56-1
|
C30H59NO5Si3
|
|
|
PROSTATESPECIFICANTIGEN(PSA),34KD,CLONE:PSA28/A4,MABANTI-HUMAN
|
|
|
|
|
prostatic binding protein
|
|
|
|
|
PROSTATICACIDPHOSPHATASE(PSAP),RABBITANTI-HUMAN
|
|
|
|
|
PROSTATETUMOROVEREXPRESSEDPROTEIN-1,CLONE:17C6,MABANTI-HUMAN:PARAFFIN,IHC
|
|
|
|
|
PROSTATICACIDPHOSPHATASE(PAP),ELISAKIT
|
|
|
|
|
PROSTATICACIDPHOSPHATASE(PSAP),CLONE:PAP-29,MABANTI-
|
|
|
|
Prosta-5,13-dien-1-oic acid, 9-(ethoxyimino)-11,15-bis[(trimethylsilyl )oxy]-, trimethylsilyl ester, (5Z,8beta,9E,11alpha,13E,15S)-
|
56085-39-3
|
C31H61NO5Si3
|
|
|
PROSTAGLANDIN E2 LIPID MAPS
|
|
|
|
Prosta-5,13-dien-1-oic acid, 9-(methoxyimino)-11,15-bis[(trimethylsily l)oxy]-, trimethylsilyl ester, (5Z,8beta,9Z,11alpha,13E,15S)-
|
39003-25-3
|
|
|
|
PROSTATIC ACID PHOSPHATASE
|
|
|
|
|
PROSTAGLANDIN F2BETA LIPID MAPS
|
|
|
|
PROSTAGLANDIN A2
|
13345-50-1
|
C20H30O4
|
|
|
Prostaglandin D synthase primers, hematopoietic form, 428bp amplimer (PGD Synthase)
|
|
|
|
|
Prostaglandin-F2-alpha (3,3,4,4-D4)
|
|
|
|
|
PROSTAGLANDIN-F2ALPHA-BSA,RABBITANTI-
|
|
|
|
|
PROSTAGLANDIN G2 LIPID MAPS
|
|
|
|
|
prosthodont
|
|
|
|
prostaglandin A2 isopropyl ester
|
114084-85-4
|
C23H36O4
|
|
|
PROSTATESPECIFICANTIGEN(PSA),34KD,CLONE:35H9,MABANTI-HUMAN:PARAFFIN,IH
|
|
|
|
Prostaglandin E2
|
363-24-6
|
C20H32O5
|
|
|
PROSTAGLANDIN K2 LIPID MAPS
|
|
|
|
|
prostaglandin D2 4-azidophenacyl ester
|
|
|
|
|
ProstaglandinHSynthase-1(Pghs-1,Cox-1)Sheep
|
|
|
|
|
ProstateSpecificMembraneAntigen(Psma)
|
|
|
|
PROSTAGLANDIN E SYNTHASE (CYTOSOLIC) BLOCKING PEPTIDE
|
|
C47H77N15O17S
|
|
|
prostatic secretory protein PSP94
|
|
|
|
|
PROSTATESPECIFICANTIGEN(PSA),34KD,CLONE:PSA28/A4,MABANTI-HUMAN:FROZEN/PARAFFIN,IH
|
|
|
|
|
prostalin
|
|
|
|
|
PROSTRATOLF
|
|
|
|
PROSTAGLANDIN H2
|
42935-17-1
|
C20H32O5
|
|
prostaglandin H2 methyl ester
|
63942-75-6
|
C21H34O5
|
|
|
PROSTATICACIDPHOSPHATASE(PAP),CLONE:PASE/4LJ,MABANTI-HUMAN:FROZEN/PARAFFIN,IH
|
|
|
|
|
prostate stem cell antigen
|
|
|
|
|
prostinogen
|
|
|
|
|
prostaglandin hydroperoxidase
|
|
|
|
|
PROSTATESPECIFICANTIGEN(PSA),CLONE:F5,MABANTI-HUMAN:PARAFFIN,IH
|
|
|
|
|
prostatodynia，PD
|
|
|
|
|
PROSTAGLANDIN F2ALPHA-BIOTINIMIDE
|
|
C35H60N4O6S
|
|
|
Prostaglandins D
|
|
|
|
|
ProstateSpecificAntigen(Psa)>=95%Pure
|
|
|
|
PROSTAGLANDIN D2
|
41598-07-6
|
C20H32O5
|
|
|
prostanoid receptor EP1
|
|
|
|
|
PROSTATEINC3SUBUNIT,RABBITANTI-RAT:WB/IH
|
|
|